The Partnership Tree Logo
 
 
 
 
 
 
Lupin Logo  
 
 
Services Profile
 
If you'd like to claim this company profile for Lupin, please Contact Us.
 

Lupin News

The latest news, announcements and press releases from Lupin.

 
 
15
December
2025
15th December 2025
 

Lupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to Scale Global Peptide Supply Chain

Mumbai, Baar, December 12, 2025: Lupin Manufacturing Solutions (LMS), a subsidiary of global pharma major Lupin Limited (Lupin), today announced a long-term strategic alliance with PolyPeptide Group AG (PolyPeptide) (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients. This collaboration aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for the rapidly expanding global peptides market. It also advances next-generation peptide therapeutics, including those for metabolics, supporting the long-term strategic growth of both organizations.

 
Read the full story »
 
 
19
December
2018
19th December 2018
 

Lupin receives US FDA approval for Clobazam Tablets, 10 mg and 20 mg

Mumbai, Baltimore, December 17, 2018: Pharma major Lupin announced that it has received approval for its Clobazam Tablets, 10 mg and 20 mg from the United States Food and Drug Administration (FDA) to market a generic version of Lundbeck Pharmaceuticals, LLC's Onfi Tablets, 10 mg and 20 mg.

 
Read the full story »
 
 
05
September
2018
05th September 2018
 

Lupin’s Tarapur API Manufacturing Facility Inspected by US FDA

Mumbai, September 4, 2018: Pharma major Lupin announced today the completion of a cGMP inspection carried out by the US FDA at its Tarapur facility. The inspection closed with one observation, a procedural deficiency. The inspection at the site was conducted between 27th and 31st August 2018 by three FDA investigators.
 
Read the full story »
 
 
16
May
2017
16th May 2017
 

Lupin completes major expansion of U.S. manufacturing facility

A U.S. generics manufacturing site that India’s Lupin picked up in its 2015 buyout of GAVIS Pharmaceuticals has now been significantly expanded as the drugmaker continues to make a push into the U.S. market.
 
Read the full story »
 
 
 

Claim This Profile

This is the News section of the company profile page for Lupin on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

 
 
Lupin company details, activities, contacts and reviews.
 
Lupin latest news, announcements and press releases.
 
Lupin legal and financial information.
 
Lupin documents, images and videos.
 
Lupin global factories, offices and locations.
 
Lupin blogs, articles and journal posts.
 
Lupin partnership and licensing opportunities.
 
 
 
 
 
 
 

About Us

The Partnership Tree established in 2003 (initially a pharmaceutical company directory) supporting companies in the finding, qualification and management of quality vendors and technical partners in the pharmaceutical. biotech and medical devices industry.

The Partnership Tree supports the finding and egagement with technical and commercial partners. It also incorporates software applications that support successful partner engagement and management. These include the building and deployment of questionnaires and assessments for vendor qualification, document excahnge, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at www.thepartnersplatform.com 

 
 
 

Get in Touch

The Partnership Tree   paul@thepartnersplatform.com

 
 

© 2026 The Partnership Tree | All Rights Reserved.